1. Home
  2. BCAB vs ASYS Comparison

BCAB vs ASYS Comparison

Compare BCAB & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • ASYS
  • Stock Information
  • Founded
  • BCAB 2007
  • ASYS 1981
  • Country
  • BCAB United States
  • ASYS United States
  • Employees
  • BCAB N/A
  • ASYS N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • ASYS Industrial Machinery/Components
  • Sector
  • BCAB Health Care
  • ASYS Technology
  • Exchange
  • BCAB Nasdaq
  • ASYS Nasdaq
  • Market Cap
  • BCAB 22.3M
  • ASYS 59.4M
  • IPO Year
  • BCAB 2020
  • ASYS N/A
  • Fundamental
  • Price
  • BCAB $0.38
  • ASYS $4.48
  • Analyst Decision
  • BCAB Buy
  • ASYS
  • Analyst Count
  • BCAB 2
  • ASYS 0
  • Target Price
  • BCAB $1.00
  • ASYS N/A
  • AVG Volume (30 Days)
  • BCAB 491.4K
  • ASYS 33.3K
  • Earning Date
  • BCAB 08-07-2025
  • ASYS 08-06-2025
  • Dividend Yield
  • BCAB N/A
  • ASYS N/A
  • EPS Growth
  • BCAB N/A
  • ASYS N/A
  • EPS
  • BCAB N/A
  • ASYS N/A
  • Revenue
  • BCAB $11,000,000.00
  • ASYS $90,826,000.00
  • Revenue This Year
  • BCAB N/A
  • ASYS N/A
  • Revenue Next Year
  • BCAB N/A
  • ASYS $28.60
  • P/E Ratio
  • BCAB N/A
  • ASYS N/A
  • Revenue Growth
  • BCAB N/A
  • ASYS N/A
  • 52 Week Low
  • BCAB $0.24
  • ASYS $3.20
  • 52 Week High
  • BCAB $2.53
  • ASYS $6.96
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 42.25
  • ASYS 59.76
  • Support Level
  • BCAB $0.36
  • ASYS $4.33
  • Resistance Level
  • BCAB $0.43
  • ASYS $4.68
  • Average True Range (ATR)
  • BCAB 0.04
  • ASYS 0.26
  • MACD
  • BCAB -0.00
  • ASYS 0.02
  • Stochastic Oscillator
  • BCAB 16.10
  • ASYS 70.51

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About ASYS Amtech Systems Inc.

Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.

Share on Social Networks: